Literature DB >> 10821928

Neurotoxicity after hypoxia/during ischemia due to glutamate with/without free radicals as revealed by dynamic changes in glucose metabolism.

T Murata1, N Omata, Y Fujibayashi, A Waki, N Sadato, M Yoshimoto, Y Wada, Y Yonekura.   

Abstract

Fresh rat brain slices were incubated with [18F]2-fluoro-2-deoxy-D-glucose ([18F]FDG) in oxygenated Krebs-Ringer solution at 36 degrees C, and serial two-dimensional time-resolved images of [18F]FDG uptake in the slices were obtained on imaging plates. The fractional rate constant of [18F]FDG (proportional to the cerebral glucose metabolic rate) from pre-loading of ischemia (O(2) and glucose deprivation)/hypoxia (O(2) deprivation) to the reperfused/reoxygenated post-loading phase was quantitatively evaluated by applying the Gjedde-Patlak graphical method to the image data. Against ischemia an N-methyl-D-aspartate antagonist and hypothermia, but not a free radical scavenger, showed a protective effect when administered during ischemia, whereas no such effect was achieved with any of the above agents when administered after reperfusion. Against hypoxia, there was no protective effect with any of the above agents when administered during hypoxia, although an effect was noted with each when administered after reoxygenation. Excitatory amino acids during ischemia loading were found to be the main factor in the neuronal damage associated with ischemia, while in hypoxia, excitatory amino acids working in tandem with free radicals immediately after reoxygenation were implicated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821928     DOI: 10.1016/s0006-8993(00)02202-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage.

Authors:  Zhong-Wei Sun; Lan Zhang; Shu-Jia Zhu; Wen-Chun Chen; Bing Mei
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

2.  A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design.

Authors:  Ori BenAri; Shai Efrati; Mary Sano; Barbara B Bendlin; HungMo Lin; Xiaoyu Liu; Inbar Sela; Ganit Almog; Abigail Livny; Israel Sandler; Simona Ben-Haim; Roy Sagi; Derek LeRoith; Michal Schnaider Beeri; Ramit Ravona-Springer
Journal:  Alzheimers Dement (N Y)       Date:  2020-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.